Fig. 3From: Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver diseaseSCFAs concentrations for each fibrosis group. Data presented as boxplots of median log2-transformed SCFAs concentrations for each fibrosis group (F0 n = 26, F1 n = 25, F2 n = 20, F3 n = 12, F4 n = 17). P-values from linear regression models adjusted for age and sex (Supplementary Table 5)Back to article page